Bottom line
How much do FBT and RYOIX overlap?
30% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 31.9% of FBT's assets and 24.2% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
RYOIX holds far more positions (74 vs 32), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBT and RYOIX have in common
| Holding | % of FBT | % of RYOIX | Overlap |
|---|---|---|---|
| Illumina Inc ILMN | 3.92% | 1.94% | 1.94% |
| Natera Inc NTRA | 3.79% | 2.12% | 2.12% |
| Neurocrine Biosciences Inc NBIX | 3.53% | 1.52% | 1.52% |
| Biogen Inc BIIB | 3.37% | 2.13% | 2.13% |
| Incyte Corp INCY | 3.18% | 1.62% | 1.62% |
| Argenx Se ARGX | 3.13% | 1.48% | 1.48% |
| Vertex Pharmaceuticals Inc VRTX | 3.07% | 4.32% | 3.07% |
| Amgen Inc AMGN | 2.78% | 5.05% | 2.78% |
| United Therapeutics Corp UTHR | 2.56% | 1.72% | 1.72% |
| Alnylam Pharmaceuticals Inc ALNY | 2.52% | 2.36% | 2.36% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBT
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Krystal Biotech Inc — 3.87%
- Axsome Therapeutics Inc — 3.71%
- Bio-techne Corp — 3.43%
- Arrowhead Pharmaceuticals Inc — 3.38%
- Exelixis Inc — 3.32%
- Halozyme Therapeutics Inc — 3.11%
- Repligen Corp — 3.07%
- Biomarin Pharmaceutical Inc — 2.83%
- Biontech Se — 2.63%
- Genmab A/s — 2.62%
Only in RYOIX
- Abbvie Inc — 8.17%
- Gilead Sciences Inc — 4.49%
- Regeneron Pharmaceuticals Inc — 2.93%
- Revolution Medicines Inc — 2.48%
- Beone Medicines Ltd — 2.17%
- Moderna Inc — 2.15%
- Royalty Pharma Plc — 2.01%
- Insmed Inc — 1.79%
- Guardant Health Inc — 1.72%
- Roivant Sciences Ltd — 1.66%
- Viatris Inc — 1.55%
- Jazz Pharmaceuticals Plc — 1.42%
- Bridgebio Pharma Inc — 1.38%
- Ionis Pharmaceuticals Inc — 1.35%
- Cytokinetics Inc — 1.35%
Asset mix
| Asset type | FBT | RYOIX |
|---|---|---|
| Stocks | 100.0% | 99.6% |
| Repurchase agreements | — | 0.6% |
| Cash & short-term funds | 0.1% | 0.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | FBT | RYOIX |
|---|---|---|
| US | 85.0% | 85.8% |
| IE | 4.2% | 2.7% |
| CH | 2.5% | 3.3% |
| GB | — | 3.2% |
| NL | 3.1% | 1.5% |
| DE | 2.6% | 1.2% |
| DK | 2.6% | 0.9% |
| BM | — | 1.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FBT and RYOIX overlap?
What stocks do FBT and RYOIX have in common?
Should I own both FBT and RYOIX?
Which holds more stocks, FBT or RYOIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.